Jun 2026 (Q2 FY26) — Aug 5, 2026
Select Water Solutions Q2 FY26 — Record Revenue and Strong Growth Across Segments
Read the full callSelect Water Solutions (WTTR) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Select Water Solutions earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 396 | +8.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 8.7 | +4.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 21.0 | +97.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$18.2 −3.35% · −$0.63
Performance +80.2% 1Y
1Y: $10.1 on 14 Oct 2025 → $18.2. High $22.26 (5 Aug 2026), low $9.4 (20 Nov 2025).
- Previous close
- $18.83
- 52-week range
- $9.4 – $22.26
- One year
- +58.12%
Overview
- Symbol
- WTTR
- Sector
- Energy
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Select Water Solutions earnings calls (WTTR)
Financials
What the filings say
Net profit, year on year: +98% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 371 | 349 | 374 | 364 | 322 | 347 | 366 | 396 |
| Operating profit | 25 | 3 | 16 | 15 | -2 | -0 | 18 | 34 |
| Operating margin | 6.6% | 0.8% | 4.2% | 4.2% | −0.6% | −0.1% | 4.9% | 8.7% |
| Interest | 2 | 2 | 5 | 6 | 6 | 7 | 6 | 5 |
| Profit before tax | 24 | 1 | 12 | 16 | 8 | -11 | 12 | 29 |
| Tax rate | 24.2% | 340.5% | 23.4% | 27.6% | 5.8% | 82.3% | 20.0% | 21.6% |
| Net profit | 16 | -2 | 8 | 11 | 3 | -0 | 9 | 21 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | 19 | 21 | -317 | -359 | -311 | -237 | -206 | -185 |
| Total liabilities | 250 | 235 | 169 | 255 | 339 | 326 | 451 | 669 |
| Fixed assets | 503 | 453 | 350 | 392 | 500 | 518 | 726 | 912 |
| Total assets | 1,361 | 1,348 | 875 | 950 | 1,223 | 1,218 | 1,366 | 1,596 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 232 | 204 | 106 | -16 | 33 | 285 | 235 | 215 |
| Cash from investing | -168 | -77 | -5 | -64 | -53 | -137 | -319 | -405 |
| Cash from financing | -49 | -65 | -11 | -3 | -58 | -98 | 47 | 188 |
| Net cash flow | 14 | 62 | 90 | -83 | -78 | 50 | -37 | -2 |
| Capital expenditure | -165 | -110 | -21 | -40 | -72 | -136 | -173 | -295 |
| Free cash flow | 67 | 94 | 85 | -56 | -39 | 149 | 62 | -80 |
Insider filings
100 filings between Nov 10, 2025 and Aug 15, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$119.51M
47 sales by 6 insiders
4% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 27
- Award — granted as compensation
- 20
- Tax withheld — shares kept back by the company to cover tax
Also filed: 2 conversions, 2 dispositions to the issuer, 2 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Crestview Partners II GP, L.P. | — | $108.30M | May 19, 2026 |
| Schmitz John | — | $7.28M | Feb 9, 2026 |
| Skarke Michael | — | $1.91M | May 12, 2026 |
| Burnett Richard Alan | — | $1.22M | May 15, 2026 |
| Fielder Robin H | — | $453.8K | May 8, 2026 |
| Szymanski Brian | — | $340.8K | May 11, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 15, 2026 | Lyons Michael James EVP, CSO & CTO | Tax withheld | 1,844 | $38.5K |
| Jul 16, 2026 | Schmitz John President & CEO | Award | 250,000 | $0 |
| Jul 2, 2026 | George Christopher Kile EVP & CFO | Tax withheld | 730 | $13.1K |
| May 19, 2026 | Crestview Partners II GP, L.P. 10% owner | Disposition to issuer | 2,632,760 | — |
| May 19, 2026 | Crestview Partners II GP, L.P. 10% owner | Conversion | 2,632,760 | — |
| May 19, 2026 | Crestview Partners II GP, L.P. 10% owner | Sale | 617,240 | $11.68M |
| May 19, 2026 | Crestview Partners II GP, L.P. 10% owner | Sale | 2,632,760 | $49.81M |
| May 15, 2026 | Burnett Richard Alan Director | Sale | 45,316 | $849.2K |
| May 14, 2026 | Burnett Richard Alan Director | Sale | 19,684 | $368.7K |
| May 12, 2026 | Skarke Michael EVP & COO | Sale | 20,000 | $355.6K |
| May 11, 2026 | Skarke Michael EVP & COO | Sale | 90,000 | $1.56M |
| May 11, 2026 | Szymanski Brian Chief Accounting Officer | Sale | 20,000 | $340.8K |
| May 8, 2026 | Fielder Robin H Director | Sale | 27,010 | $453.8K |
| May 6, 2026 | Burleson Gayle Director | Award | 9,446 | $0 |
| May 6, 2026 | Burnett Richard Alan Director | Award | 9,446 | $0 |
| May 6, 2026 | FERNANDEZ-MORENO LUIS M Director | Award | 9,446 | $0 |
| May 6, 2026 | Fielder Robin H Director | Award | 9,446 | $0 |
| May 6, 2026 | Roberts Timothy A. Director | Award | 9,446 | $0 |
| May 6, 2026 | Cope Bruce E. Director | Award | 9,446 | $0 |
| Apr 8, 2026 | Crestview Partners II GP, L.P. 10% owner | Sale | 665,983 | $10.07M |
| Apr 8, 2026 | Crestview Partners II GP, L.P. 10% owner | Disposition to issuer | 2,430,240 | — |
| Apr 8, 2026 | Crestview Partners II GP, L.P. 10% owner | Sale | 2,430,240 | $36.75M |
| Apr 8, 2026 | Crestview Partners II GP, L.P. 10% owner | Conversion | 2,430,240 | — |
| Apr 1, 2026 | WILSON ROBERT ALLEN SVP, General Counsel & CCO | Award | 25,552 | $0 |
| Apr 1, 2026 | WILSON ROBERT ALLEN SVP, General Counsel & CCO | Award | 24,138 | $0 |
| Mar 5, 2026 | Skarke Michael EVP & COO | Award | 29,450 | $0 |
| Mar 5, 2026 | Ortowski Cody EVP, Business Strategy | Tax withheld | 10,846 | $152.2K |
| Mar 5, 2026 | Ortowski Cody EVP, Business Strategy | Award | 27,561 | $0 |
| Mar 5, 2026 | Schmitz John President & CEO | Tax withheld | 49,420 | $693.4K |
| Mar 5, 2026 | Skarke Michael EVP & COO | Tax withheld | 11,589 | $162.6K |
| Mar 5, 2026 | Lyons Michael James EVP, CSO & CTO | Award | 10,602 | $0 |
| Mar 5, 2026 | Szymanski Brian Chief Accounting Officer | Tax withheld | 7,843 | $110.0K |
| Mar 5, 2026 | Lyons Michael James EVP, CSO & CTO | Tax withheld | 3,430 | $48.1K |
| Mar 5, 2026 | Szymanski Brian Chief Accounting Officer | Award | 17,885 | $0 |
| Mar 5, 2026 | George Christopher Kile EVP & CFO | Tax withheld | 10,103 | $141.7K |
| Mar 5, 2026 | George Christopher Kile EVP & CFO | Award | 25,674 | $0 |
| Mar 5, 2026 | Schmitz John President & CEO | Award | 125,590 | $0 |
| Feb 24, 2026 | Skarke Michael EVP & COO | Award | 38,394 | $0 |
| Feb 24, 2026 | Ortowski Cody EVP, Business Strategy | Award | 32,552 | $0 |
| Feb 24, 2026 | Lyons Michael James EVP, CSO & CTO | Tax withheld | 7,821 | $106.8K |
| Feb 24, 2026 | Lyons Michael James EVP, CSO & CTO | Award | 34,221 | $0 |
| Feb 24, 2026 | George Christopher Kile EVP & CFO | Tax withheld | 14,656 | $200.1K |
| Feb 24, 2026 | George Christopher Kile EVP & CFO | Award | 44,714 | $0 |
| Feb 24, 2026 | Szymanski Brian Chief Accounting Officer | Tax withheld | 11,022 | $150.5K |
| Feb 24, 2026 | Szymanski Brian Chief Accounting Officer | Award | 18,988 | $0 |
| Feb 24, 2026 | Ortowski Cody EVP, Business Strategy | Tax withheld | 14,694 | $200.6K |
| Feb 24, 2026 | Skarke Michael EVP & COO | Tax withheld | 15,701 | $214.3K |
| Feb 24, 2026 | Schmitz John President & CEO | Award | 143,084 | $0 |
| Feb 24, 2026 | Schmitz John President & CEO | Tax withheld | 66,952 | $913.9K |
| Feb 23, 2026 | Schmitz John President & CEO | Gift | 265,250 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Select Water Solutions, Inc.
Free account. Everything above stays public.
Write why you follow Select Water Solutions, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading